MIRA INFORM REPORT

 

 

Report No. :

317488

Report Date :

10.05.2015

 

IDENTIFICATION DETAILS

 

Name :

NANO THERAPEUTICS PRIVATE LIMITED

 

 

Registered Office :

201- B, Ventura Shopping Centre Avenue, Near D- Mart, Hiranandani Business Park, Powai, Mumbai – 400076, Maharashtra

Tel No. :

91-261-6450898

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

28.05.2008

 

 

Com. Reg. No.:

11-182771

 

 

Capital Investment / Paid-up Capital :

Rs. 20.000 Million

 

 

CIN No.:

[Company Identification No.]

U33114MH2008PTC182771

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMN16180D

 

 

PAN No.:

[Permanent Account No.]

AACCN7849M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, Marketer and Trader of Endo/Cardio Vascular machinery and equipment.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 100000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow But Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Reserves of the company seems to be low during 2014. However, General financial position of the company seems to be decent.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Shakil Shaikh

Designation :

Manager

Contact No.:

91-9879699196

Date :

24.04.2015

 

 

LOCATIONS

 

Registered Office :

201- B, Ventura Shopping Centre Avenue, Near D- Mart, Hiranandani Business Park, Powai, Mumbai – 400076, Maharashtra, India

Tel. No.:

91-22-28772221

Mobile No.:

91-9879699196 (Mr. Shakil Shaikh)

Fax No.:

Not Available

E-Mail :

Shakil@nano-therapeutic.net

nanoterapeutics@drdcs.net

Website :

Not Available

 

 

Factory  :

Plot No. D – 54/2, Hojiwala Industrial Estate, Road No. 23, Near Gate No. 3, Sachin Palsana Highway, Surat – 394230, Gujarat, India

 

 

DIRECTORS

 

As on: 30.09.2014

 

Name :

Mr. Samir kumar Kanjibhai Koladia

Designation :

Director

Address :

301-A, Swagat Apartment, Sahnip Park, B/H Sneh Sankul Wadi, Mahal Road, Adajan,  Surat-395009, Gujarat, India

Date of Birth/Age :

19.06.1974

Date of Appointment :

03.06.2010

DIN No.:

01665553

 

 

Name :

Jayantilal Limbabhai Nariya

Designation :

Whole Time Director

Address :

36, Shraddhadeep Bungalows, causeway Road, Singanpore Road, Surat – 395008, Gujarat, India

Date of Birth/Age :

25.12.1964

Date of Appointment :

30.08.2011

DIN No.:

00265683

 

 

Name :

Mr. Rohitbhai Bababai Koladia

Designation :

Director

 

 

Name :

Mr. Manoj Kumar Parshotam Movaila

Designation :

Director

 

 

Name :

Mr. Manoj Kumar PArshotam Movaila

Designation :

Director

 

 

Name :

Ms. Vanita Rajesh Vaishnav

Designation :

Director

 

 

Name :

Mr. Parth Rajesh Vaishnav

Designation :

Director

 

 

Name :

Mr. Satyavijay Ganesh Parab

Designation :

Director

 

 

Name :

Mrs. Vibhuti Satya Vijay Parab

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Shakil Shaikh

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.09.2014

 

Names of Shareholders

No. of Shares

%age

Rajesh Laljibhai Vaishanv

890000

44.50

Parth Rajesh Bhai  Vaishanv

336000

16.80

Vinita Rajesh Bhai Vaishnav

474000

23.70

Abhishek Mashalawala

100000

5.00

Jayanti Limbabhai Nariya

100000

5.00

Viral Laljibhai Vaishnav

100000

5.00

Total

2000000

100.00

 

 

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

95.00

Other top fifty shareholders

5.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Marketer and Trader of Endo/Cardio Vascular machinery and equipment.

 

 

Products :

  • CURATIS Cobalt Chromium Renal and Biliary Stent System
  • Curo – Cobalt Chromium Coronary Stent System
  • Xpirator – Thrombus Aspiration Catheter
  • Navus  Sirolimus Eluting Coronary Stent System
  • Invo Shield – Emboli Protective Stent System
  • Superiaa Sirolimus Eluting Coronary Stent System

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • Turkey
  • Malaysia
  • Iran
  • Spain

 

 

Imports :

 

Products :

Raw Material

Countries :

France

 

 

Terms :

 

Selling :

Cash and L\C

 

 

Purchasing :

Cash and L\C

 

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

NATEC

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Experience :

Not Available

Maximum Limit Dealt :

Not Available

 

 

Customers :

 

Reference :

Not Available

Name of the Person :

Not Available

Contact No.:

Not Available

Since How Long Known :

Not Available

Experience :

Not Available

Maximum Limit Dealt :

Not Available

 

 

No. of Employees :

Not Divulged 

 

 

Bankers :

  • HDFC Bank, Surat, Gujarat, India
  • Dena Bank, Burhanpuri Bhagal, Bhagal, Surat – 395003, Gujarat, India
  • Axis Bank
  • Kotak bank

 

 

Facilities :

(Rs. In Million)

SECURED LOAN

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Term Loan from Bank

 

 

-       Rupee term loan bank

9.886

16.521

 

 

 

SHORT TERM BORROWING

 

 

Loans Repayable on Demand from Bank

 

 

-       Working Capital Loan

16.966

19.958

 

 

 

Total

26.852

36.479

 

Auditors :

 

Name :

 Shirish Desai and Company

Chartered Accountants

Address :

312, 5th Floor, New Opera House, Above Kiran Motor, Civil Crossing to Sosyo Circle way, Khatodara, Surat- 395002, Gujarat, India

PAN No.:

AAPFS2232R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Related Parties :

Anderson Biomed Private Limited

 

 

CAPITAL STRUCTURE

 

As on: 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

Rs.10/- each

Rs. 20.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

Rs.10/- each

Rs. 20.000 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

20.000

20.000

20.000

(b) Reserves & Surplus

17.202

10.478

5.068

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

37.202

30.478

25.068

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

27.630

35.038

47.967

(b) Deferred tax liabilities (Net)

1.215

0.938

0.786

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

28.845

35.976

48.753

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

16.967

19.958

11.590

(b) Trade payables

13.920

4.858

6.658

(c) Other current liabilities

12.370

9.375

10.136

(d) Short-term provisions

0.430

0.552

0.920

Total Current Liabilities (4)

43.687

34.743

29.304

 

 

 

 

TOTAL

109.734

101.197

103.125

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

54.288

55.839

59.211

(ii) Intangible Assets

4.018

2.161

2.881

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

6.158

3.718

1.940

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.019

0.021

0.051

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

64.483

61.739

64.083

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

24.693

11.098

6.938

(c) Trade receivables

15.467

26.652

24.785

(d) Cash and cash equivalents

2.488

0.295

2.453

(e) Short-term loans and advances

2.478

1.244

4.663

(f) Other current assets

0.125

0.169

0.203

Total Current Assets

45.251

39.458

39.042

 

 

 

 

TOTAL

109.734

101.197

103.125

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

96.319

103.767

85.855

 

 

Other Income

0.483

0.422

0.370

 

 

TOTAL                                    

96.802

104.189

86.225

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

33.362

31.081

0.000

 

 

Other expenses

41.413

46.141

69.246

 

 

TOTAL                                    

74.775

77.222

69.246

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

22.027

26.967

16.979

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

7.904

5.702

1.799

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

14.123

21.265

15.180

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

5.238

12.204

7.960

 

 

 

 

 

 

PROFIT BEFORE TAX

8.885

9.061

7.220

 

 

 

 

 

Less

TAX                                                                 

2.162

3.652

2.286

 

 

 

 

 

 

PROFIT AFTER TAX

6.723

5.409

4.934

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

29.925

30.816

7.152

 

TOTAL IMPORTS

29.925

30.816

7.152

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.36

2.70

3.60

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

6.98

5.21

5.75

 

 

 

 

 

Operating Profit Margin

(PBDIT / Sales)

(%)

22.87

25.99

19.78

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.58

9.30

7.14

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.24

0.30

0.29

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.20

1.80

2.38

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.04

1.14

1.33

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

20.000

20.000

20.000

Reserves & Surplus

5.068

10.478

17.202

Net worth

25.068

30.478

37.202

 

 

 

 

long-term borrowings

47.967

35.038

27.630

Short term borrowings

11.590

19.958

16.967

Total borrowings

59.557

54.996

44.597

Debt/Equity ratio

2.376

1.804

1.199

 

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

85.855

103.767

96.319

 

 

20.863

(7.178)

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

85.855

103.767

96.319

Profit

4.934

5.409

6.723

 

5.75%

5.21%

6.98%

 

 

 


 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

No

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

Yes

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

Note:

Registered office of the company has been shifted from A  - 2501, 25th Floor, Mahindra Eminent, Near Patkar College, S.V. Road, Goregaon (west),Mumbai – 400062, Maharashtra, India to the present address w.e.f.28.04.2011

 

 

UNSECURED LOAN

(Rs. In Million)

Particulars

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Loan and advances from related parties

 

 

-       Anderson Biomed Private Limited

17.745

18.517

 

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 

 

FIXED ASSETS

 

  • LAND
  • Plot At Hojiwala
  • Factory Building
  • Plant and machinery
  • Equipment
  • Furniture and Fixtures
  • Computers
  • Trademark
  • Patent

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.40

UK Pound

1

Rs.95.42

Euro

1

Rs.68.48

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUP

 

 

Analysis Done by :

RSM

 

 

Report Prepared by :

ART


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY 

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

3

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavorable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.